Report Code : CVMI24071659 | Published Date : July 16, 2024

The Calcium Channel Blocker Market is experiencing steady growth, fueled by the increasing incidence of hypertension, a rising prevalence of cardiovascular diseases, and advancements in antihypertensive drug formulations. The market, valued at USD 15.3 billion in 2023, is expected to grow at a CAGR of 5.45% from 2024 to 2031, reaching USD 24.1 billion by 2031.

Key Market Insights

Calcium channel blockers (CCBs) are a widely used class of antihypertensive and cardiovascular drugs that are essential for managing blood pressure, treating angina, and controlling arrhythmias. There is a growing demand for long-acting formulations, combination therapies, and next-generation CCBs increasing.

Growth Drivers

  • Rising Global Burden of Hypertension and Cardiovascular Diseases – Increasing aging populations and sedentary lifestyles are contributing to this trend demand.
  • Advancements in Extended-Release and Combination CCB Formulations – The development of once-daily, sustained-release formulations improves treatment adherence
  • Growing Adoption of Personalized Cardiology Treatment Approaches – The shift towards genotype-guided hypertension therapies is enhancing patient outcomes outcomes.
  • Regulatory Approvals and Government Support for Cardiovascular Drug Accessibility – Expanded healthcare coverage for hypertension treatment plans is driving the market growth.

 

Regional Trends

  • North America leads due to high cardiovascular disease prevalence and strong R&D in antihypertensive drugs.
  • Europe is expanding with government-backed cardiovascular health programs and access to innovative CCBs.
  • Asia-Pacific is rapidly growing, driven by rising hypertension cases and improving healthcare access.
  • Latin America & MEA are emerging markets benefiting from expanding cardiology-focused healthcare programs.

 

Analyst View

The Calcium Channel Blocker Market is set for continuous expansion, driven by technological advancements in CCB formulations, increasing awareness of hypertension management, and growing adoption of combination antihypertensive therapies. Companies investing in long-acting drug delivery, AI-powered cardiology diagnostics, and next-generation calcium channel blockers will dominate this evolving sector.





Reasons To Buy

nan





Scope

nan

Key Players

  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • AstraZeneca plc
  • Sanofi S.A.

 

Global Calcium Channel Blocker Market Report

  1. 1. Global Calcium Channel Blocker Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Calcium Channel Blocker Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Calcium Channel Blocker Market Research Report - Preface
    1. 2.1 Global Calcium Channel Blocker Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Type
      2. 2.1.2 By Indication
      3. 2.1.3 By Distribution Channel
      4. 2.1.4 By Region
    3. Global Calcium Channel Blocker Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Type, By Indication, By Distribution Channel, By Country
    3. 3.3. Opportunities – By Type, By Indication, By Distribution Channel, By Country
    4. 3.4. Trends – By Type, By Indication, By Distribution Channel, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Calcium Channel Blocker Market Research Report – DROTs Impact Analysis
    4. Global Calcium Channel Blocker Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Calcium Channel Blocker Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Dihydropyridines (Amlodipine
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Nifedipine)
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Non-Dihydropyridines (Verapamil
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 5.4 Diltiazem)
      1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Calcium Channel Blocker Market, By Indication, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Hypertension
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Angina Pectoris
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Arrhythmias
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Calcium Channel Blocker Market, By Distribution Channel, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Hospital Pharmacies
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Retail Pharmacies
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Online Pharmacies
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Calcium Channel Blocker Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 8.5 Middle East & Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 8.6 Global Calcium Channel Blocker Market - Opportunity Analysis Index, By Type, By Indication, By Distribution Channel, and Region, 2024 - 2031
    9. North America Global Calcium Channel Blocker Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Dihydropyridines (Amlodipine
      2. 9.1.2 Nifedipine)
      3. 9.1.3 Non-Dihydropyridines (Verapamil
      4. 9.1.4 Diltiazem)
      9.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Hypertension
      2. 9.2.2 Angina Pectoris
      3. 9.2.3 Arrhythmias
      9.3 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Hospital Pharmacies
      2. 9.3.2 Retail Pharmacies
      3. 9.3.3 Online Pharmacies
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
      9.5 North America Global Calcium Channel Blocker Market – Opportunity Analysis Index, By Type, By Indication, By Distribution Channel, and Country, 2024 - 2031
      9.6 Regional Trends Analysis
      9.7 North America Global Calcium Channel Blocker Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Global Calcium Channel Blocker Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Dihydropyridines (Amlodipine
      2. 10.1.2 Nifedipine)
      3. 10.1.3 Non-Dihydropyridines (Verapamil
      4. 10.1.4 Diltiazem)
      10.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Hypertension
      2. 10.2.2 Angina Pectoris
      3. 10.2.3 Arrhythmias
      10.3 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Hospital Pharmacies
      2. 10.3.2 Retail Pharmacies
      3. 10.3.3 Online Pharmacies
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 United Kingdom
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Netherlands
      8. 10.4.8 Poland
      9. 10.4.9 Rest of Europe
      10.5 Europe Global Calcium Channel Blocker Market – Opportunity Analysis Index, By Type, By Indication, By Distribution Channel, and Country, 2024 - 2031
      10.6 Regional Trends Analysis
      10.7 Europe Global Calcium Channel Blocker Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (United Kingdom)
      3. 10.7.3 Company 3 (United Kingdom)
    11. Asia-Pacific Global Calcium Channel Blocker Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Dihydropyridines (Amlodipine
      2. 11.1.2 Nifedipine)
      3. 11.1.3 Non-Dihydropyridines (Verapamil
      4. 11.1.4 Diltiazem)
      11.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Hypertension
      2. 11.2.2 Angina Pectoris
      3. 11.2.3 Arrhythmias
      11.3 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Hospital Pharmacies
      2. 11.3.2 Retail Pharmacies
      3. 11.3.3 Online Pharmacies
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 China
      2. 11.4.2 Japan
      3. 11.4.3 India
      4. 11.4.4 South Korea
      5. 11.4.5 Australia & NZ
      6. 11.4.6 ASEAN
      7. 11.4.7 Rest of Asia-Pacific
      11.5 Asia-Pacific Global Calcium Channel Blocker Market – Opportunity Analysis Index, By Type, By Indication, By Distribution Channel, and Country, 2024 - 2031
      11.6 Regional Trends Analysis
      11.7 Asia-Pacific Global Calcium Channel Blocker Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (China)
      2. 11.7.2 Company 2 (Japan)
      3. 11.7.3 Company 3 (Japan)
    12. Latin America Global Calcium Channel Blocker Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Dihydropyridines (Amlodipine
      2. 12.1.2 Nifedipine)
      3. 12.1.3 Non-Dihydropyridines (Verapamil
      4. 12.1.4 Diltiazem)
      12.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Hypertension
      2. 12.2.2 Angina Pectoris
      3. 12.2.3 Arrhythmias
      12.3 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Hospital Pharmacies
      2. 12.3.2 Retail Pharmacies
      3. 12.3.3 Online Pharmacies
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Peru
      5. 12.4.5 Colombia
      6. 12.4.6 Rest of Latin America
      12.5 Latin America Global Calcium Channel Blocker Market – Opportunity Analysis Index, By Type, By Indication, By Distribution Channel, and Country, 2024 - 2031
      12.6 Regional Trends Analysis
      12.7 Latin America Global Calcium Channel Blocker Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East & Africa Global Calcium Channel Blocker Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Dihydropyridines (Amlodipine
      2. 13.1.2 Nifedipine)
      3. 13.1.3 Non-Dihydropyridines (Verapamil
      4. 13.1.4 Diltiazem)
      13.2 By Indication Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Hypertension
      2. 13.2.2 Angina Pectoris
      3. 13.2.3 Arrhythmias
      13.3 By Distribution Channel Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Hospital Pharmacies
      2. 13.3.2 Retail Pharmacies
      3. 13.3.3 Online Pharmacies
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Saudi Arabia
      2. 13.4.2 UAE
      3. 13.4.3 South Africa
      4. 13.4.4 Egypt
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
      13.5 Middle East & Africa Global Calcium Channel Blocker Market – Opportunity Analysis Index, By Type, By Indication, By Distribution Channel, and Country, 2024 - 2031
      13.6 Regional Trends Analysis
      13.7 Middle East & Africa Global Calcium Channel Blocker Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Saudi Arabia)
      2. 13.7.2 Company 2 (UAE)
      3. 13.7.3 Company 3 (UAE)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
      14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 Pfizer Inc.
      2. 14.2.2 Novartis AG
      3. 14.2.3 Bayer AG
      4. 14.2.4 AstraZeneca plc
      5. 14.2.5 Sanofi S.A.
    15. Data Collection Method and Research Approach
    16. Principal Presumptions and Acronyms



    2.